Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy
Authors
Keywords
-
Journal
JAMA Dermatology
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2022-06-01
DOI
10.1001/jamadermatol.2022.1736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ASTRO Editorial: ONS Guidelines for Cancer Treatment-Related Radiodermatitis
- (2021) Carol Madellaine Marquez et al. Practical Radiation Oncology
- Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation
- (2021) Tomoya Yokota et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review
- (2021) Sofiane Allali et al. Cancers
- Global disparities in breast cancer outcomes: new perspectives, widening inequities, unanswered questions
- (2020) Mojisola Oluwasanu et al. Lancet Global Health
- Topical Betamethasone Valerate As a Prophylactic Agent to Prevent Acute Radiation Dermatitis in Head and Neck Malignancies: A Randomized, Open-Label, Phase 3 Trial
- (2020) Abhilash Menon et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A prospective, three-arm, randomized trial of EGCG for preventing radiation-induced esophagitis in lung cancer patients receiving radiotherapy
- (2019) Hanxi Zhao et al. RADIOTHERAPY AND ONCOLOGY
- Evaluation of acute skin toxicity of breast radiotherapy using thermography: Results of a prospective single-centre trial
- (2018) O. Maillot et al. Cancer Radiotherapie
- A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation
- (2018) Alice Y. Ho et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature
- (2018) Fiorenza De Rose et al. BREAST
- Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
- (2017) Charlotte E Coles et al. LANCET
- Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule
- (2017) Eva Ulff et al. RADIOTHERAPY AND ONCOLOGY
- Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy
- (2016) Hanxi Zhao et al. BRITISH JOURNAL OF RADIOLOGY
- Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy
- (2016) Wanqi Zhu et al. Oncotarget
- Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
- (2015) Harry Bartelink et al. LANCET ONCOLOGY
- Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule
- (2015) Reshma Jagsi et al. JAMA Oncology
- Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Patients Receiving Breast Radiation Therapy: Results of a Randomized Trial
- (2014) Andrew Hindley et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression
- (2014) W. Zhu et al. JOURNAL OF RADIATION RESEARCH
- Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial
- (2013) Umberto Veronesi et al. LANCET ONCOLOGY
- Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group
- (2013) Rebecca K. S. Wong et al. SUPPORTIVE CARE IN CANCER
- Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase III Double-Blind, Randomized Trial From the North Central Cancer Treatment Group N06C4
- (2010) Robert C. Miller et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comparison of Provider-Assessed and Patient-Reported Outcome Measures of Acute Skin Toxicity During a Phase III Trial of Mometasone Cream Versus Placebo During Breast Radiotherapy: The North Central Cancer Treatment Group (N06C4)
- (2010) Michelle A. Neben-Wittich et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Breast Intensity-Modulated Radiation Therapy Reduces Time Spent With Acute Dermatitis for Women of All Breast Sizes During Radiation
- (2009) Gary M. Freedman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Skin Penetration of Epigallocatechin-3-Gallate and Quercetin from Green Tea and Ginkgo biloba Extracts Vehiculated in Cosmetic Formulations
- (2009) S.E. dal Belo et al. SKIN PHARMACOLOGY AND PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started